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Abstract The combination of redox enzymes for redox-neutral
cascade reactions has received increasing appreciation. An ex-
ample is the combination of an alcohol dehydrogenase (ADH)
with a cyclohexanone monooxygenase (CHMO). The ADH can
use NADP+ to oxidize cyclohexanol to form cyclohexanone and
NADPH. Both products are then used by CHMO to produce ε-
caprolactone. In this study, these two redox-complementary en-
zymes were fused, to create a self-sufficient bifunctional enzyme
that can convert alcohols to esters or lactones. Three different
ADH genes were fused to a gene coding for a thermostable
CHMO, in both orientations (ADH-CHMO and CHMO-
ADH). All six fusion enzymes could be produced and purified.
For two of the three ADHs, we found a clear difference between
the two orientations: one that showed the expected ADH activity,
and one that showed low to no activity. TheADHactivity of each
fusion enzyme correlated with its oligomerization state. All fu-
sions retained CHMO activity, and stability was hardly affected.
The TbADH-TmCHMO fusion was selected to perform a cas-
cade reaction, producing ε-caprolactone from cyclohexanol. By
circumventing substrate and product inhibition, a > 99% conver-
sion of 200 mM cyclohexanol could be achieved in 24 h, with >
13,000 turnovers per fusion enzyme molecule.
Keywords Enzyme fusion . Cascade . Cyclohexanone
monooxygenase . Alcohol dehydrogenase
Introduction
The use of enzymes for industrial-scale production of
chemicals has great potential. Enzymatic reactions allow the
production of specific compounds without the use of harsh
chemicals, organic solvents or extreme conditions, such as
high temperature and high pressure. With multi-step enzymat-
ic reactions, also referred to as cascade reactions, complex
compounds can be produced in a single setup, with minimal
input and without the need of isolating intermediates
(Muschiol et al. 2015; Xue and Woodley 2012).
There are several problems preventing the large-scale in-
dustrial application of enzymatic reactions (Woodley 2013).
One important hurdle is stability; enzymes evolved to catalyze
reactions at the level of a living cell, and cannot maintain
production for long periods of time, with co-solvents, and at
higher temperatures. Another frequently encountered issue is
insufficient functional expression, in particular when the en-
zyme which presents the rate-limiting step in a cascade has a
limited level of expression. Furthermore, general availability
of enzymes can be an issue, and to improve expression of
enzymes individually is comparatively costly.
An approach that could address some of these difficulties is
producing catalytically complementary enzymes fused to each
other. Fusions are generally created by organizing a single open
reading frame coding for two or more enzymes, from which the
translationwould result in amultifunctional enzyme. Some stud-
ies on enzyme fusions have found various advantages, including
improved catalytic efficiency, expression, folding and stability
(Chen et al. 2013; Yang et al. 2016). In some cases, as the fused
enzymes are in close proximity, a product molecule from one
enzyme could directly migrate to the active site of the second
enzyme. This phenomenon is referred to as substrate channeling
(Wheeldon et al. 2016). In this way, a cascade reaction with
fused enzymes can be more efficient (Iturrate et al. 2010).
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Although some studies have found particular benefits from
fused enzymes, it is not clear how to design an efficient and
stable fusion. The current state of the art of fusions has been
reviewed recently (Elleuche 2015; Yang et al. 2016).
The aim of this study is to investigate fusion engineering as
an approach to co-express and improve biocatalysts in terms of
stability and catalytic efficiency. We fused alcohol dehydroge-
nases (ADHs, EC 1.1.1) to a Baeyer-Villiger monooxygenase
(BVMO, EC 1.14.13), as the two types of enzymes can perform
various cascade reactions together. ADHs can oxidize alcohols
to ketones, whereby NADPH is formed, and a BVMO can then
use the NADPH and oxygen to oxidize the ketones to lactones
or esters. The cascade reaction we aimed to optimize with this
approach is the biocatalytic production of ε-caprolactone from
cyclohexanol (Fig. 1), which has been targeted in various recent
studies (Mallin et al. 2013; Staudt et al. 2013; Sattler et al. 2014;
Schmidt et al. 2015).
The BVMO that was used for each fusion is the recently
characterized cyclohexanone monooxygenase from
Thermocrispum municipale (TmCHMO) (Romero et al.
2016). The CHMO is more thermostable and has higher sol-
vent tolerance than the commonly used AcCHMO from
Acinetobacter calcoaceticus NCIMB 9871. Therefore, the
TmCHMO is a promising biocatalyst for industrial application.
Three ADH enzymes were chosen as fusion partners for the
TmCHMO, based on their preference for NADP+ and thermo-
stability. Two are known thermostable enzymes: TbADH from
Thermoanaerobacter brockii (Lamed et al. 1981) and ADHA
from Pyrococcus furiosus (Van der Oost et al. 2001). The other
one is a newly discovered alcohol dehydrogenase: ADHMi
from Mesotoga infera. We identified the respective gene of
the latter ADH by searching the genome sequence database
for predicted proteins showing sequence similarity with anno-
tated cyclohexanol dehydrogenases while being from a
mesophile, and predicted to accept NADP+ as coenzyme using
Cofactory (Geertz-Hansen et al. 2014).
Fusions between the ADHs and TmCHMO were made in
both orientations, with the TmCHMO either at the C-terminus
or at the N-terminus of the ADH (Table 1). In this way, six
fusion constructs were created in total. The rationale for this
approach is that either of the enzymes could be hindered by its
fusion partner in one orientation. In particular, ADHs form
oligomers, and the oligomerization may be obstructed, which
could decrease their stability (Korkhin et al. 1999), and could
prevent their activity (Breiter et al. 1994). The two enzymes
are connected by a glycine-rich linker, which in a previous
study on fusions was found to be the most favorable among
the tested linkers (Jeon et al. 2015).
We intended to create a fusion that can convert cyclohexanol
to ε-caprolactone in vitro, which is stable for a long period of
time at elevated temperatures, leading to high total turnover
numbers. Activity of both enzymes of the fusions was deter-
mined, and their stability and oligomerization were studied.
The best candidate was used to perform conversions of
cyclohexanol into ε-caprolactone.
Materials and methods
Materials, strains and culture media
Oligonucleotide primers for cloning and mutagenesis were
ordered from Sigma-Aldrich. For amplification of the gene
inserts, PfuUltra II HotStart PCR master mix was used,
purchased from Agilent Technologies. Other chemicals
were purchased from Sigma-Aldrich and Acros Organics.
Precast native PAGE gradient gels were ordered from Bio-
Rad. CAL-A lipase was ordered from c-LEcta. As host
strain for recombinant DNA, Escherichia coli NEB® 10-
beta (New England Biolabs) was used. Precultures were
grown in lysogeny broth (LB), and the subsequent main
cultures in terrific broth (TB).
Cloning of fusion constructs
The TmCHMO gene was amplified from an in-house plasmid
(pBAD-His-Tag-SUMO-TmCHMO; Romero et al. 2016)
using PCR with two primer sets that have different flanking
regions which contain restriction sites (Table S1). After PCR
purification, the two obtained fragments were separately
cloned into a pBAD vector. This vector has a region coding
Fig. 1 Cascade reaction from cyclohexanol to ɛ-carpolactone,
involving an alcohol dehydrogenase (ADH) and a cyclohexanone
monooxygenase (CHMO)
Table 1 Fusion constructs
Enzyme N-terminal Linker C-terminal Mw
(kDa)
A-Tm ADHA Glycine-rich TmCHMO 90
Tm-A TmCHMO Glycine-rich ADHA 90
Mi-Tm ADHMi Glycine-rich TmCHMO 91
Tm-Mi TmCHMO Glycine-rich ADHMi 91
Tb-Tm TbADH Glycine-rich TmCHMO 102
Tm-Tb TmCHMO Glycine-rich TbADH 102
Each fusion construct also contained a His-tag at the N-terminal side.
Molecular weight of each fusion is based on predicted size and SDS-
PAGE. Glycine-rich linker amino acid sequence: SGGSGGSGGSAG
Appl Microbiol Biotechnol
for a glycine-rich linker (SGGSGGSGGSAG), which is be-
tween two cloning sites, and the vector has an N-terminal His-
tag. One PCR fragment was inserted into theNdeI-XhoI site of
one vector, and the other between the PvuII and HindIII sites
of another vector, using restriction and ligation. In this way,
two vectors were obtained: one containing the TmCHMO
gene at the N-terminal side of the glycine-rich linker, and
one at the C-terminal side. To multiply the two vectors, the
recombinant plasmids were used to transform chemically
competent E. coli NEB® 10-beta cells. To identify colonies
that had the desired insert, colony PCR was done, using a
gene-specific forward and a vector-specific reverse primer.
Colonies that gave PCR product were subsequently analyzed
using Sanger sequencing (GATC Biotech). Cells harboring
the correct plasmids were stored at − 80 °C in 25% glycerol.
For subsequent subcloning of the three ADH genes, the two
vectors that contain the TmCHMO gene were used as back-
bones. The Tbadh (X64841.1) gene was obtained from an in-
house plasmid (pBad::HheC::AdhT; Szymanski et al. 2010); a
plasmid containing the adhA gene was previously received
from the laboratory of microbiology at Wageningen
University (Van der Oost et al. 2001); adhMi (CCU83614.1)
was ordered as a codon-optimized synthetic gene
(MF276894) and was subcloned from the supplied standard
vector (GenScript, USA). The genes were amplified using two
primer sets (Table S1), and all the other steps described above
were repeated for each ADH gene, with a few exceptions. To
avoid digestion in the middle of either gene of one construct,
first, adhA was cloned into the starting vector at the PvuII-
ApaI site, and subsequently, the TmCHMO gene was inserted
at the NdeI-XhoI site. Thus, six fusion constructs were cloned
that have either the ADH gene or TmCHMO gene at the N-
terminal side, and the other gene at the C-terminal end. For
expression of the individual adh genes, fusion constructs with
the adh upstream of the linker region were mutated with
QuickChange primers, thereby introducing a stop codon at
the end of each adh gene.
Expression and protein purification
E. coli cells harboring the plasmids containing a gene fusionwere
grown overnight at 37 °C in 5 mL LB and 50 μg/mL ampicillin.
The precultures were inoculated from the − 80 °C glycerol
stocks. On the next day, the precultures were used to inoculate
50 mL of TB, containing 50 μg/mL ampicillin and 0.02% (w/v)
L-arabinose, in baffled flasks. The 50mL cultures were incubated
at 24 °C for 40 h. The cells were then harvested (3000×g, 4 °C),
and then resuspended in 10 mL of 50 mM Tris/HCl pH 8.0.
Resuspended or pelleted cells were stored at − 20 °C.
To purify the expressed proteins, the cell suspension was
subjected to sonication for 10min after thawing, and the lysate
was centrifuged for 45 min at 29,100×g (JA-17 rotor,
Beckman, 4 °C). The supernatant was filtered through a
membrane (0.45 μm pore size), and the filtrate was mixed
with 1 mL of Ni2+ Sepharose resin (GE Healthcare), which
was pre-equilibrated with 50 mM Tris/HCl pH 8.0. The mix-
ture was incubated in closed gravity-flow column for 60 min
at 4 °C while rotating. After the liquid was let through the
column, the resin was washed with six column volumes of
three solutions consisting of buffer (50 mM Tris/HCl pH
8.0) and varying concentrations of imidazole: 0, 5 and 10
mM. Subsequently, the bound proteins were eluted by apply-
ing 500 mM imidazole in 50 mM Tris/HCl pH 8.0. The ob-
tained yellow elute was then applied to a PG-10 desalting
column which was pre-equilibrated with 50 mM Tris/HCl
pH 8.0, and the protein was eluted with the same buffer.
Protein analyses
From the fractions obtained during purification (cell-free extract,
flow-through, wash, purified), 10 μL samples of 2 mg/mL pro-
tein were taken. After addition of SDS loading dye and incuba-
tion at 95 °C for 5min, the samples were spun down at 13,000×g
for 1 min, and then loaded onto an SDS-PAGE gel (GenScript,
USA) and run according to the recommendations of the gel
supplier. A protein ladder (PageRuler pre-stained, Thermo
Fisher) was also loaded. The gels were run in a Mini-
PROTEAN® Tetra Vertical Electrophoresis Cell (Bio-Rad),
and current was applied using a PowerPacTM HC High-Current
Power Supply (Bio-Rad), set at 120V.When the blue front of the
loading dye reached the bottom of the gel, the gel was removed
from the chamber, rinsed with water and stained with Coomassie
InstantBlueTM (Fig. S1). Absorption spectra from 200 to 700 nm
were taken of each purified fusion protein and diluted in buffer in
a quartz cuvette (V-330 Spectrophotometer, JASCO). Using the
obtained values at 280 and 441 nm, the protein concentration
(ɛ441 = 14.0 mM
−1 cm−1) and FAD ratio could be calculated.
Activity assays
Kinetic measurements were done by following the formation or
depletion of NADPH at 340 nm. After mixing enzyme (≤ 0.1
μM) with substrate in buffer (50 mM Tris/HCl pH 8.0),
200 μM NADP or NADPH was added, briefly mixed in a
cuvette, and then the reaction was followed (V-330
Spectrophotometer, JASCO). For ADH activity, cyclohexanol
(10 mM final concentration) was used as substrate, and for
CHMO activity thioanisole (0.25 mM final concentration).
The slopes of the initial 20 s were used to calculate the activity
rates. The obtained slope value is expressed in absorption
change per minute (Abs/min). This value was then divided by
the extinction coefficient of NADPH (ɛ340 = 6.22 mM
−1 cm−1),
in accordance with Lambert-Beer law, giving a value in milli-
molar per minute. By dividing this value by the protein con-
centration in the reaction, the kobs values were obtained. All
measurements were done in duplicates or triplicates.
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Blue native PAGE and zymography
Native PAGE with all purified enzyme fusions was performed
as described (Wittig et al. 2006), with some modifications.
The cathode buffer consisted of 50 mM tricine, 7.5 mM im-
idazole, 0.002% w/v Coomassie blue G-250 (pH 7.0), the
anode buffer of 25 mM imidazole (pH 7.0), and the sample
loading dye of 50% glycerol and 0.5% Ponceau S (w/v).
Samples were prepared bymixing 5 μL of fusion enzymewith
5 μL of loading dye, and they were loaded onto the gel (4–
15% Mini-PROTEAN® TGX™, Bio-Rad). The gel electro-
phoresis was started at 60 V (10 mA, 1W) at 4 °C, the voltage
was increased by 10 every 30 min, and after 2 h, the gel was
removed. The gel was washed with water, and then incubated
with a zymography reaction solution (2 mM phenazine
methosulfate (PMS), 0.3 mM nitro-blue tetrazolium (NBT),
0.5 mM NADP+, 50 mM cyclohexanol, in 50 mM Tris/HCl
pH 9.0) for 20 min at 25 °C. The reaction mixture was re-
moved when clear purple spots appeared in the gel, and the gel
was subsequently stained with 0.02% (w/v) Coomassie blue
G-250 in fixing solution (methanol:acetic acid:dH2O
40:10:50), and finally destained with 8% acetic acid solution.
Gel filtration
Purified enzyme fusion samples were applied to a gel filtration
column (Superdex 200 10/300 GL, GE Healthcare), which
was equilibrated with buffer (50 mM Tris/HCl, 150 mM
NaCl, pH 7.5) and mounted onto an ÄKTA pure system
(GE Healthcare), and the flow rate was set at 0.6 mL/min of
the same buffer. Through detection at 280 and 450 nm, the
elution of the fusion enzymes could be followed in time. A gel
filtration standard (Bio-Rad) was applied in the same way, and
based on the elution times, a calibration curve was made,
which was used to calculate the molecular weight of the fusion
enzyme complexes.
Melting point determination and stability
To determine the melting temperature of each fusion and the
individual enzymes, samples were analyzed using the
ThermoFluor® and ThermoFAD method (Forneris et al. 2009).
Samples of 20μL, containing 10μMof enzyme, were incubated
in a real-time PCR machine with a temperature gradient (20–99
°C, + 0.5 °C/min) while measuring fluorescence every 0.5 °C
step. For the ThermoFluor® method, the dye SYPRO® orange
(Thermo Fisher) was added to the samples. The determined val-
ue of melting temperature is the average value of two measure-
ments. Long-term stability was evaluated by incubating 10 μM
of enzyme in potassium phosphate buffer (100 mM, pH 8.0) at
37 °C andmeasuring the activity rates at various time points. For
activity rate determination of the alcohol dehydrogenase, 10mM
of cyclohexanol and 0.20 mM NADP+ were used, and for the
cyclohexanonemonooxygenase activity, 0.25mMof thioanisole
with 0.20 mM NADPH was used. All measurements were per-
formed in duplicate.
Conversions
Small-scale biotransformations were performed in 2 mL
Eppendorf tubes, with 0.5 mL of reaction mixture. The mixture
consisted of fusion enzyme (5–20 μM), cofactor (200 μM
NADP+), CAL-A lipase (10 mg/mL) and buffer (50 mM Tris/
HCl pH 8.0 or 0.5 M potassium phosphate buffer pH 8.0). A
control without fusion enzyme was run in parallel. The tubes
with the reactions were incubated (37 °C, 600 RPM,
ThermoMixer C, Eppendorf). During the incubation, substrate
(stock 1 M cyclohexanol in buffer) was fed into the tubes with a
syringe pump at a rate of 5 μL/h (Syringe Pump NE-4000). In
later experiments, 10 mg/mL CAL-A lipase (c-LEcta) was in-
cluded in the reactions. The samples were extracted three times
with equivalent volume of ethyl acetate, including 1.0 mM of
acetophenone as external standard. The pooled extract (1.5 mL)
was dried with magnesium sulfate and then analyzed using GC-
MS (HP-5 column, injection temperature 250 °C, oven temper-
ature 40–130 °C, 5 °C/min).
Submission of sequence
The codon-optimized nucleotide sequence coding for ADHMi
from Mesotoga infera was submitted to GenBank according
to the instructions of the website of GenBank. The amino acid
sequence was originally obtained from NCBI (GenBank acces-
sion CCU83614.1). To order the corresponding synthetic gene,
the amino acid sequence was submitted to GenScript, which
produced the codon-optimized gene for expression in E. coli.
Results
Expression and purification of fusion enzymes
After cloning of each fusion construct (Table 1), transformed
cells were grown for expression of the fusion enzymes.
Expression was induced simultaneously with inoculation of
the main culture, and this culture was incubated for 40 h at
24 °C. Purification of the yellow fusion enzymes was
achieved through nickel affinity chromatography (Fig. S1).
The imidazole was removed by applying the yellow fraction
to a desalting column and subsequent elution with buffer. The
purification yielded substantial protein amounts, which varied
from 120 to 320 mg per liter culture. Similar amounts were
obtained from expression and purification of the single ADH
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enzymes and TmCHMO, which suggests that the expression
of the fusions is at least just as good (no data shown). In
practice, expression with 50 mL cultures yielded a sufficient
amount for biochemical experiments.
The degree of FAD cofactor in the fusion enzymes can be
verified by measuring the absorption at 441 and 280 nm.
Incorporation of this cofactor could be affected by the level
of expression, as there could be insufficient FAD in the cell,
and by hindrance from the fusion partner. Bound FAD is a
sign of correctly folded flavoprotein. FAD ratios (A280/A441)
of the fusions were found to range from 14 to 17, which
indicates that the majority of each fused TmCHMO has
FAD bound after purification (Table S2). From here on, the
fusions will be abbreviated as follows: A-Tm (ADHA-
TmCHMO), Mi-Tm (ADHMi-TmCHMO) and Tb-Tm
(TbADH-TmCHMO) for the N-terminal ADH fusions
(ADH-CHMO), and the fusions with a C-terminal ADH
(CHMO-ADH) inversely (Tm-A, Tm-Mi and Tm-Tb).
Activity screening
To determine the activity of each fusion enzyme, change in
absorption at 340 nm was followed, as described in the
BMaterials and methods^ section. The ADH oxidation rate
was determined with 10 mM cyclohexanol as substrate.
Cyclohexanone is also a substrate for the ADHs, for the re-
duction reaction with NADPH. Therefore, the BVMO activity
of the fusion enzymes was measured using thioanisole (0.25
mM) as substrate (Table 2). The activity of TmCHMO on
thioanisole is very similar to its activity on cyclohexanone
(Romero et al. 2016).
It was gratifying to note that every fusion retained activity
of the TmCHMO fusion partner. Overall, the BVMO activity
was fairly consistent, aside from a two-fold decrease with Mi-
Tm, and some fusions having slightly higher rates.
Conversely, the alcohol oxidation activities of the fusions var-
ied more severely. Neither A-Tm nor Tm-A showed any
cyclohexanol oxidation activity. Interestingly, for the fusion
Mi-Tm, no activity was observed, whereas Tm-Mi did show
clear oxidation rates. With the fusions of TbADH, the reverse
was observed: Tb-Tm has a wild-type level of activity, where-
as Tm-Tb had a four-fold lower activity.
Previous studies on the cascade reaction from cyclohexanol
to ɛ-caprolactone (Fig. 1) have used AcCHMO and pointed
out that it is inactivated and inhibited by cyclohexanol, and by
ɛ-caprolactone (Mallin et al. 2013; Staudt et al. 2013). It is
important to know whether this also applies to TmCHMO,
since inhibition could negatively affect the productivity of
the cascade. Inhibition of TmCHMO was studied at several
concentrations of inhibitor, and thioanisole was used as sub-
strate to determine the activity. The single TmCHMO as well
as the Tm-A fusion were tested. Regarding product inhibition,
a 50% reduction of activity was observed in the presence of
66 mM of ε-caprolactone, and an 80% reduction at 133 mM.
Results with cyclohexanol showed that presence of 2 mMwas
sufficient to cause a decrease in activity of 75% (data not
shown). Like AcCHMO, TmCHMO also suffers from
inhibition, though it is more robust.
Oligomerization of fusion enzymes
Alcohol dehydrogenases typically form dimers or tetra-
mers, which in most cases is needed for stability and/or
activity. Two techniques were used to investigate the olig-
omerization behavior of the fusion enzymes: blue native
PAGE (BN-PAGE) combined with zymography and gel
filtration chromatography.
After BN-PAGE, the gel was subjected to zymography,
which causes active ADHs to show a dark purple band (Fig. 2
and Fig. S2). The following enzymes showed no activity: both
of the ADHA fusions and Tm-Tb. Minor activity was seen for
Mi-Tm, whereas the other enzymes showed clear dark bands
(Tm-Mi and Tb-Tm). Coomassie staining revealed that, aside
from the two ADHA fusions, every inactive fusion also had a
higher electrophoretic mobility compared to their active coun-
ter-parts, which suggests possible structural changes. When
comparing two fusions consisting of identical proteins, e.g.
Mi-Tm with Tm-Mi, it seems that each active fusion has lower
electrophoretic mobility, indicative of a distinct structural
organization.
Protein size was estimated using gel filtration chromatog-
raphy (Fig. S3). In accordance with results from the BN-
PAGE, oligomers above 400 kDa were determined for the
fusions A-Tm, Tm-A, Tm-Mi and Tb-Tm, which









A-Tm < 0.01 1.4
Tm-A < 0.01 1.8
ADHMi 0.11 –





Change in absorption at 340 nm measured at 25 °C in 50 mM Tris/HCl
pH 8.0. Final substrate concentrations used: 10 mM cyclohexanol and
0.25 mM thioanisole. Cofactor concentration: 100 μM NADP+ or
NADPH, respectively. For ADHMi and its fusions, 100 μM NAD+
was used for the alcohol oxidation. Reaction rates were calculated with
protein concentrations determined from absorbance at 441 nm, using the
extinction coefficient of TmCHMO (ɛ441 = 14.0 mM
−1 cm−1 )
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supports the impression that these fusion enzymes form tetra-
mers. Each individual ADH had an elution time correspond-
ing to homodimers. The fusion enzyme Tm-Tb has a main
peak at its monomer size, while for the Mi-Tm fusion,
a trimer size of about 280 kDa was observed.
Enzyme stability
Since the fusion enzymes consist of a single polypeptide
chain, the stability and the tendency to unfold could be
changed compared to the individual enzymes. For each fu-
sion enzyme, the melting point was determined by using
ThermoFluor and ThermoFAD (Table S2). With the latter,
the release of the FAD from TmCHMO upon unfolding
could be detected, while with ThermoFluor, any protein
unfolding gives a signal by binding of a dye (SYPRO or-
ange). The more stable ADHs transfer some stability to
TmCHMO (ΔTm of up to +3 °C). The results from
ThermoFluor have va lues s imi la r to those f rom
ThermoFAD. This is due to the lower melting point of
TmCHMO compared to the ADHs.
The fusions Mi-Tm, Tm-Mi and Tb-Tm display a second
melting peak in the ThermoFluor assay (Fig. S4). In each case,
the second peak is some degrees lower than the single ADH
melting point. For instance, the Tm of the single ADHMi is 69
°C, while the second peak of the Tm-Mi fusion is at 65 °C.
This suggests that in those fusions each fusion partner unfolds
more independently than the individual ADH.
To evaluate long-term stability, Tb-Tm was incubated at 37
°C for 42 h (Fig. S6). Residual ADH and TmCHMO activity
was determined by monitoring the change in absorption at
340 nm after addition of substrate and nicotinamide cofactor.
The long-term incubationwas also carried out for TbADH and
TmCHMO as separate enzymes. The fusion retained slightly
more activity: after 42 h, the fusion had 92% of the ADH and
Fig. 2 Blue native PAGE stained
with Coomassie and zymography
simultaneously. The HMW
Native Marker ladder (GE
Healthcare) values are given in
kDa. The dark, purple stain results
from the zymography, whereas
the lighter, blue stain is caused by
the Coomassie blue G-250
treatment
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BVMO activity, whereas the separate TbADH and TmCHMO
retained 88 and 82% activity, respectively.
Conversions
The most active and stable fusion was selected to perform
small-scale conversions with cyclohexanol. Based on the re-
sults from the other experiments, the Tb-Tm fusion was se-
lected. Biocatalytic production of ε-caprolactone was per-
formed by combining the Tb-Tm fusion with NADP+ and
cyclohexanol (Table 3). The total volume of each conversion
was 0.5 mL. After conversion for 24 h at 37 °C, the reaction
sample was extracted three times with ethyl acetate, dried with
magnesium sulfate and then analyzed using GC-MS (HP-5
column) (Fig. S5). The percentage of conversion is defined
by depletion of substrate (cyclohexanol) and intermediate (cy-
clohexanone), compared to the control with enzyme.
Initial experiments (15 μM Tb-Tm, 200 μM NADP+, 24 h,
37 °C) on low (10 mM) substrate concentration gave 100%
conversion, while high (> 100 mM) substrate loadings gave
near to 0% conversion. The latter result can be explained by
the TmCHMO inhibition by cyclohexanol. Therefore, substrate
(1 M concentration) was fed into the reaction with a syringe
pump at 5 μL/h (Syringe Pump NE-4000) to attain more con-
version with higher substrate loading. By this, a conversion of
64% could be achieved in 24 h. To investigate whether product
inhibition was the main cause of the incomplete conversion,
CAL-A lipase was included in the reactions, as described in a
previous study (Schmidt et al. 2015). This lipase can convert ε-
caprolactone to oligo-caprolactone, thereby reducing product
inhibition. After incubation of the reaction including CAL-A
(10mg/mL) for 24 h, the conversion reached 80.5%. The pH of
the reaction drastically decreased during the conversion; from
pH 8.0 to 5.0 after 24 h, which is likely due to hydrolysis by the
CAL-A lipase. To maintain pH, experiments were continued in
a high concentration of potassium phosphate buffer (0.5 M, pH
8.0), which was tested with each enzyme for activity and sta-
bility (data not shown). This enabled us to get > 99%
conversion of 200 mM cyclohexanol within 24 h. If a turnover
is defined as the transformation of one molecule of
cyclohexanol to one molecule of ɛ-caprolactone, then each
fusion molecule performed 13,333 turnovers (TON), and
NADP+ 1000 turnovers. Intriguingly, a parallel reaction was
performed with the TbADH and TmCHMO as separate en-
zymes, which gave a conversion of only 42%.
To investigate which of the two enzymes is rate-limiting,
conversions with the fusion (5 μM) and an additional amount
of either the TbADH or TmCHMO (5 μM) were made, such
that the ratio between the two enzymes was 2:1 or 1:2
(Table 3). The reaction with additional TbADH reached
95.8% conversion after 24 h, whereas the one with
TmCHMO reached > 99%, showing that the TmCHMO is
the slowest fusion partner.
Discussion
In this study, we designed ADH–TmCHMO fusion con-
structs, expressed the genes in E. coli cells and then purified
the fusion enzymes. Good amounts of FAD-containing fusion
enzymes could be produced and purified. For studies on
multi-enzyme reactions, the required enzymes are typically
produced individually. By enzyme fusion, a single expression
and purification yields bifunctional enzymes, thereby greatly
reducing the effort and possibly improving the expression.
Moreover, in some cases, a fusion can perform successive
reactions more efficiently, as found in various studies so far
(Iturrate et al. 2010; Jeon et al. 2015; Lerchner et al. 2016;
Peters et al. 2017).
However, we have found that this co-expression does not
always produce fully active fusion enzymes. In particular, some
of the fusions lacked ADH activity, while the TmCHMO
retained activity in each of the six fusions. One of the ADHs
that was fused is the ADHA fromP. furiosus, which has extraor-
dinary thermostability with a reported half-life of 22.5 h at 90 °C









Tb-Tm (15 μM) 200 24 37 > 99% 13,333
TbADH (15 μM) + TmCHMO (15 μM) 200 24 37 42% 5600
Tb-Tm (5 μM) + TbADH (5 μM) 200 24 37 95.8% 19,160
Tb-Tm (5 μM) + TmCHMO (5 μM) 200 24 37 > 99% 20,000
Tb-Tm (20 μM) 500 48 30 41.5% 10,375
TbADH (20 μM) + TmCHMO (20 μM) 500 48 30 33% 8250
Conversions included substrate feeding (cyclohexanol, 1 M) at 5 μL/h, and 10 mg/mL CAL-A lipase, in 0.5 M
potassium phosphate buffer pH 8.0. Conversion is calculated based on the depletion of cyclohexanol (and
intermediate, cyclohexanone), from the GC-MS measurements. TON = Turnover number, per fusion molecule,
regarding the transformation of cyclohexanol to ε-caprolactone as one turnover
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poor, in particular at lower temperatures. Considering this fact, it
was not surprising to find that ADHA and its fusions were
unable to oxidize cyclohexanol at 25 °C. Unlike this lack of
activity of ADHA and its fusions, the reason for the inactivity
ofMi-Tm ismore obscure. The individual ADHMi enzyme, and
its fusion Tm-Mi, are capable of oxidizing cyclohexanol.
Therefore, the lack of activity is probably caused by the orien-
tation, i.e. the fusion of the BVMO at the C-terminal side of the
ADH. Incidentally, ADHMi is a short-chain dehydrogenase
(SDR superfamily, with 250 amino acids on average). A recent
study pointed out that for Lactobacillus kefir RADH, also an
SDR, a C-terminal His-tag was detrimental for its activity
(Peters et al. 2017). Furthermore, levodione reductase from
Leifsonia aquatica had 40–70% decrease in activity with a C-
terminally fused aminotransferase, depending on the linker
length (Lerchner et al. 2016). The findings point to a common
trend for SDR enzymes, where a fusion tag or enzyme at the C-
terminal side of the SDR is disruptive for its activity.
In addition to lack of activity, the fusion Mi-Tm showed a
smaller oligomeric size based on gel filtration, indicating that
it forms a trimer. A plausible explanation for this aberration is
that the region at the C-terminal side of the ADHMi is part of
the oligomerization interface. The association between four
ADH subunits would be hindered by the BVMO domains that
are located at this interface. Consequently, the ADH is unable
to form a particular oligomer, which could be needed for sta-
bility and activity (Breiter et al. 1994). On the other hand, the
Tm-Mi fusion shows a tetramer size with the gel permeation
experiments, and activity with zymography and spectrophoto-
metric assay.
For the fusions with TbADH, a medium-chain reductase
(MDR) enzyme, the situation is reversed. In this case, the
fusion Tb-Tm has wild-type activity, while Tm-Tb has a
four-fold lower ADH activity. The effect is less drastic com-
pared to that of the ADHMi. The finding is in line with a study
on phosphite dehydrogenase (PTDH)-BVMO fusions (Torres
Pazmiño et al. 2008). In that study, the PAMO-PTDH fusion
has 1.5-fold lower PTDH activity compared to the PTDH-
PAMO fusion. Possibly, MDR enzymes favor the latter orien-
tation in general, while showing a decrease in activity in the
reverse orientation. As withMi-Tm, the low activity of Tm-Tb
correlates with a different oligomeric state, indicating a mono-
mer, while the more active Tb-Tm seems to form a tetramer.
Previous studies on biocatalytic ε-caprolactone production
have used AcCHMO, which was found to be inhibited by
cyclohexanol and by ε-caprolactone. We found that, com-
pared to AcCHMO, the TmCHMO, though more thermosta-
ble, is also prone to inhibition. This property is unfortunate for
the cascade reaction with Tb-Tm, as the KM for cyclohexanol
of the TbADH (7 mM) is higher than the estimated KI for
cyclohexanol (< 2 mM) of TmCHMO. Based on the conver-
sions in which either enzyme was added in a 2:1 ratio, the
BVMO was shown to be the bottleneck of the cascade
reaction. Therefore, the TmCHMO inhibition is an important
aspect to investigate in future studies, in order to improve
productivity of cascade reactions with these fusion enzymes.
The fusion Tb-Tm was selected to perform the cascade
reaction to produce ε-caprolactone, as it showed the highest
activity on cyclohexanol. Multiple adjustments had to be
made in order to get more conversion. Inhibition of
TmCHMO by substrate and product needed to be addressed,
as well as the decrease in pH, which is probably the result of ε-
caprolactone hydrolysis by CAL-A, as it would form 6-
hydroxyhexanoic acid. The decrease in pH reduces the stabil-
ity and the rates of the enzymes. In particular, the oxidation
rate of ADHs is dependent on pH, as the deprotonation of the
alcohol is favored at higher pH, which promotes oxidation of
the alcohol. With substrate feeding, addition of CAL-A lipase,
and by using a strong buffer, > 99% of 200 mM cyclohexanol
could be converted in 24 h. This result shows that the fusion
can continuously perform oxidations by recycling of the co-
factor, with a turnover number (TON) of > 13,000 for the
fusion enzyme. In a study with a similar cascade, in which
AcCHMO was used, the enzyme reached a TON of approxi-
mately 5800 (Bornadel et al. 2016), which suggests that the
superior stability of TmCHMO enables higher turnover num-
bers. The fusion seems to perform better than the combined
individual enzymes. Several factors could play a role in this
difference: slightly worse stability of the non-fused
TmCHMO (Table S2, Fig. S6), higher activity of the
TmCHMO in the Tb-Tm fusion (Table 2), and possibly a
benefit of the co-localization of the two enzymes, as the cy-
clohexanone and NADPH formed by the ADH could directly
migrate to the active site of the TmCHMO.
Conversions with relatively high final substrate concentra-
tions showed difficulties due to solubility, enzyme stability
and inhibition. When the activity of the TmCHMO decreases,
while the substrate feeding rate remains equal, the process will
eventually stop due to complete inhibition of TmCHMO by
the accumulated cyclohexanol. This effect also explains why
factors, such as small differences in stability and activity, com-
bined could lead to incomplete conversions, as was observed
with the separate enzymes. It might be possible to convert
more substrate if the substrate feeding flow is decreased in
proportion to the decrease of active enzyme, or if additional
enzyme is added. The intricate balancing of the kinetic param-
eters and stability of the three enzymes involved in the
cyclohexanol to 6-hydroxyhexanoic acid cascade reaction
was recently investigated (Scherkus et al. 2017). The authors
used computational simulations, as well as experiments, to
find the most favorable approach and conditions for large-
scale conversions. In a similar cascade, involving an enoate
reductase in addition to ADH and CHMO, kinetic modeling
was applied to identify bottlenecks for in vivo biotransforma-
tions (Milker et al. 2017). The kinetic models described could
be applied to the robust Tb-Tm fusion presented herein, to
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further optimize the cascade towards an industrial process for
ɛ-caprolactone production. Notably, as both the ADH and
CHMO can accept a broad range of substrates, the fusions
can be used for the production of various interesting esters
or lactones through analogous cascade reactions.
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